70% of patients consider online reviews important when selecting a healthcare provider and 75% of people have searched for a physician online according to a recent survey from Patientpop. With reviews playing such a pivotal role in discovery, gathering reviews is not only essential as a marketing tool but also as a mechanism for clinicians to address issues that may be resulting in less than stellar patient satisfaction. Doctify is the tech-enabled healthcare review platform that provides both patients and healthcare providers with valuable insights. Founded by two physicians in 2015, the platform also offers patients the ability to schedule appointments and teleconsultations. Doctify is offered on a subscription basis to the healthcare provider and is free to use for patients. London TechWatch caught up with CEO and Cofounder Stephanie Eltz to learn more about the business, the company’s strategic expansion plans to further support its mission to keep both patients and healthcare providers informed, latest funding round from investors that include Keen Venture Partners, Amadeus Capital, Guinness Asset Management, and Tom Teichman.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 15/4/2021 featuring funding details for Cado Security and much more.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 14/4/2021 featuring funding details for LOKE, Loyalize, and much more.
Everything you need to need to know about the largest London startup funding rounds of Q1 2021; broken down by industry, stage, investors, and more…
The latest venture capital, seed, pre-seed, and angel deals for London startups for 12/4/2021 featuring funding details for Thirdfort and much more.
London Tech News for the week ending 10/4 featuring news for Eola, Zedsen, and much, much more…
The global fertility market is estimated to grow to ~$50B by 2030 with nearly 1/8 couples having trouble conceiving. Advances in technology are making reproductive health options more accessible from both a convenience and affordability standpoint. Bea Fertility is a healthcare startup offering at-home fertility treatments via a kit offered through subscription. Traditional fertility options like IVF need to be done at a fertility center and come at exorbitant cost. Bea uses ICI, a technique that’s similarly effective to other treatment options, but only costs £300/month. The company is focused on supporting the entire conception journey and offers ovulation tracking, guidance, and an expert network. Presently pre-launch, Bea is in the process of gaining regulatory approval and expects to launch by the end of the year. London TechWatch caught up with CEO and Cofounder Tess Cosad to learn more about the importance of making fertility treatments accessible, the company’s upcoming launch, strategic plans, and recent round of funding from Calm/Storm VC and QVentures.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 9/4/2021 featuring funding details for TrueLayer, Yhangry, and much more.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 7/4/2021 featuring funding details for Neurocess and much more.
The best single month total in London history with $2.2B+ in funding raised, fueled by strong late-stage activity with 5 mega ($100M) rounds.